Emily Hill

Emily Hill

Director of Finance/CFO at REPLIMUNE GROUP, INC.

Net worth: 898 659 $ as of 2024-03-30

44 year
Health Technology
Consumer Services
Finance

Profile

Emily Hill is currently the Chief Financial Officer at Replimune Group, Inc. She previously worked as the Director at Greenhill Humane Society SPCA, Senior Manager-Investor Relations at Genzyme Corp., Associate-Biotech Equity Research at Summer Street Capital Partners LLC, Head-Investor Relations Contact at Warner Chilcott Plc, and SVP & Head-Investor Relations at PTC Therapeutics, Inc. Ms. Hill received her undergraduate degree from Hamilton College (New York), her graduate degree from Tufts University School of Medicine, and her MBA from Fordham Gabelli School of Business.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-03-31 109,995 ( 0.18% ) 898 659 $ 2024-03-30
2023-04-12 0 ( -.--% ) - $ 2024-03-30

Emily Hill active positions

CompaniesPositionStart
REPLIMUNE GROUP, INC. Director of Finance/CFO 2023-09-18
All active positions of Emily Hill

Former positions of Emily Hill

CompaniesPositionEnd
Investor Relations Contact -
Investor Relations Contact 2009-12-31
Corporate Officer/Principal -
PTC THERAPEUTICS, INC. Director of Finance/CFO -
Director/Board Member -
See the detail of Emily Hill's experience

Training of Emily Hill

Hamilton College (New York) Undergraduate Degree
Tufts University School of Medicine Graduate Degree
Fordham Gabelli School of Business Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Emily Hill's experience

Connections

100 +

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
PTC THERAPEUTICS, INC.

Health Technology

REPLIMUNE GROUP, INC.

Health Technology

Private companies4

Health Technology

Finance

Commercial Services

Health Technology

See company connections